Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccineMaryam Esmaily, Farhad Jadidi‐Niaragh, Ali Masjedi et al.|Journal of Controlled Release|2020Cited by 94
Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responsesMitra Ghasemi‐Chaleshtari, Farhad Jadidi‐Niaragh, Hadi Hassannia et al.|Journal of Cellular Physiology|2020Cited by 50
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapyAli Masjedi, Farhad Jadidi‐Niaragh, Armin Ahmadi et al.|Nanomedicine Nanotechnology Biology and Medicine|2020Cited by 49
Corrigendum to “Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240]Ali Masjedi, Farhad Jadidi‐Niaragh, Armin Ahmadi et al.|Nanomedicine Nanotechnology Biology and Medicine|2023Cited by 0
Retraction notice to “Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression” [Life Sci. 275 (2021) 119369]Navneet Joshi, Farhad Jadidi‐Niaragh, Farnaz Hajizadeh et al.|Life Sciences|2025Cited by 0